Expanding access to anti-obesity medications delivers 13% return on investment for society
A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...
I lost 10 and a half stone on Mounjaro – people said I’d ‘always be a bigger girl’ but it’s totally changed my life
A MOTHER has revealed that she has lost 10 and a half stone after using Mounjaro.  Becca Banks, a mum-of-one from the UK, ...
1 Growth Stock With Major Catalysts on the Way to Buy and Hold
After starting 2024 strong, Eli Lilly (NYSE: LLY) did not perform well in the second half of last year. Its financial results ...
Rolling Out11h
The unsettling truth your type 2 diabetes has been hiding
New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...
Rolling Out8h
Your diabetes diagnosis might be warning you about cancer
Research reveals a hidden connection between diabetes and cancer. Learn how your blood sugar levels might impact your long-term health.
The $3 drink loved by celebrities that burns fat like Ozempic
A cheap canned drink available at nearly every corner store may burn fat as well as - or even better than - than blockbuster ...
pharmaphorum23h
Novo Nordisk, Lilly highlight oral obesity drugs at ADA
but extending its use into non-diabetic obesity could unlock an even larger market for the drug. A once-weekly injectable form of the drug is sold as Wegovy and has also seen strong uptake since ...